Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.87
-2.69%
After-hours: Aug 15, 2025, 06:51 PM EDT

Lyra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.84M -79.53M -93.44M -97.61M -101.39M -68.88M -62.68M -61.76M -65.66M -64.52M -55.28M -54.66M -46.17M -42.72M -43.51M -36.92M -32.2M -25.7M
Depreciation & Amortization
-1.56M -1.55M -1.54M -1.6M 298K 130K 278K 415K 762K 1.07M 1.07M 1.12M 1.19M 1.21M 1M 764K 447K 157K
Stock-Based Compensation
5.17M 5.38M 6.72M 6.26M 6.21M 6.44M 5.89M 6.16M 6.46M 6.21M 5.45M 4.47M 3.47M 3.02M 2.77M 2.58M 2.31M 2.28M
Other Working Capital
180K 499K -309K -72K -911K -2.08M -5.33M -7.98M -3.98M 2.47M 6.18M 9.74M 4.55M 12.13M 11.57M 11.81M 14.67M -1.77M
Other Non-Cash Items
-4.25M 20.13M 20.44M 24.81M 26.29M 3.08M 3.28M 8K 2.18M 3.88M 11.67M 24.77M 24.72M 23.02M 16.24M 1.44M 331K -931K
Deferred Income Tax
n/a n/a n/a -5.19M -5.19M -5.19M -5.19M n/a n/a -2.67M -2.67M -16.59M -16.59M -13.92M -13.92M 879K 879K 879K
Change in Working Capital
-3.52M -828K -2.2M -4.38M -1.83M -5.49M -4.88M -1.24M 4.23M 9.81M 4.55M 6.55M -478K 8.36M 13.92M 13.18M 15.62M -1.41M
Operating Cash Flow
-43.01M -56.4M -70.01M -77.72M -75.61M -69.91M -63.3M -56.41M -53.14M -47.33M -43.38M -42.52M -41.99M -30.14M -25.82M -20.39M -13.86M -24.72M
Capital Expenditures
-13K -189K -2.34M -3.18M -3.28M -3.15M -1.05M -288K -173K -116K -164K -1.22M -1.71M -2.32M -3.38M -3.4M -3.48M -2.93M
Cash Acquisitions
n/a n/a n/a n/a 14.84M 15.32M 15.32M 15.32M 490K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-12.81M -27.42M -47.95M -97.61M -127.63M -138.51M -122.42M -137.61M -94.77M -69.28M -64.84M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
49.07M 100.06M 130.59M 150.6M 157.6M 131.62M 110.89M 62.8M 34.8M 9.8M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
18K n/a n/a n/a -14.84M -15.32M -15.32M -80.17M -65.33M -64.84M -64.84M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
36.27M 72.45M 80.31M 49.81M 26.7M -10.04M -12.58M -75.09M -60.15M -59.6M -65.01M -1.22M -1.71M -2.32M -3.38M -3.4M -3.48M -2.93M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.62M -121K -287K -609K -1.01M 46.28M 46.45M -150.22M -150.03M -100.73M -100.73M 96.25M 96.41M 103K 359K 370K -221K 58.5M
Financial Cash Flow
4.62M -113K 8.53M 27.45M 27.06M 74.33M 65.69M -49.72M -49.54M -238K -236K 96.25M 96.41M 103K 359K 370K -221K 58.5M
Net Cash Flow
-2.12M 15.94M 18.23M -1.05M -22.46M -6.22M -10.2M -84.73M -66.33M -10.67M -12.13M 52.52M 52.71M -32.35M -28.85M -23.42M -17.55M 30.86M
Free Cash Flow
-43.02M -56.59M -72.35M -80.9M -78.88M -73.06M -64.35M -56.7M -53.31M -47.45M -43.55M -43.74M -43.69M -32.45M -29.2M -23.79M -17.33M -27.64M